UCL researchers launch congenital muscular dystrophy research programme
The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK
Read Moreby Emily Kimber | Apr 23, 2025 | News | 0
The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK
Read Moreby Lucy Parsons | Oct 26, 2020 | News | 0
Trial will investigate chemotherapy drug to alleviate hallucinations in people with Parkinson’s
Read Moreby Selina McKee | Sep 4, 2020 | News | 0
Four papers have been published reinforcing evidence that steroids can significantly improve the outcomes for those critically ill with the virus
Read Moreby Selina McKee | Aug 25, 2020 | News | 0
The model suggests that just 13% of full-time academics would have been available to carry out research during the height of the pandemic
Read Moreby Selina McKee | Jul 23, 2020 | News | 0
The funds will be used to further developed tech that enables earlier detection of eye disease
Read Moreby Selina McKee | Jul 21, 2020 | News | 0
Deerfield is partnering on the development of a novel gene therapy
Read Moreby Selina McKee | May 28, 2020 | News | 0
Researchers are hopeful that this ‘ground-breaking approach’ could accelerate the prediction of which patients are more at risk of their disease returning
Read Moreby Selina McKee | Dec 12, 2018 | News | 0
A ‘revolutionary’ new medical software able to pinpoint the area from which surgeons should take a biopsy to detect prostate cancer has been developed by NIHR supported researchers.
Read Moreby Selina McKee | Dec 6, 2018 | News | 0
The first drug candidate from Eisai and University College London (UCL)’s drug discovery collaboration is to enter Phase I clinical trials for Alzheimer’s disease (AD) early next year.
Read Moreby Selina McKee | Sep 7, 2018 | News | 0
Imperial College London, UCL and Eli Lilly have formed an alliance that strives to transform medicines manufacturing in England.
Read Moreby Selina McKee | Apr 27, 2018 | News | 0
Research led by University College London (UCL) and the University of Leeds, with support from a Cancer Research UK/Bupa Foundation Innovation Award, has revealed widespread public belief in “mythical causes” of cancer.
Read Moreby Selina McKee | Feb 14, 2018 | News | 0
Researchers are calling for a national database of high opioid users after finding that the number prescriptions and related deaths in England is on the rise, especially in poorer communities.
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479